REQUEST A DEMO
Total
USD $0.00
Search more companies

Ucb Pharma Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing | Warehousing and Storage | Administrative Management and General Management Consulting Services | All Other Support Services
Full name: Ucb Pharma Sp. z o.o. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Ucb Pharma Sp. z o.o is an international biofarmaceutical company. They have been operating in Poland for over 30 years, with an office located in Warsaw. The company focuses on therapeutic solutions in neurology, immunology, and oncology, as well as cardiological products. Ucb Pharma Sp. z o.o provides therapeutic solutions for people suffering from severe diseases. Their portfolio includes antihistaminic drugs, immunotherapy, and corticosteroids for the treatment of allergies, as well as Briviact 10 mg/ml solution for injections and Prostavasin 60 powder for preparing the solution for infusion.

Headquarters
Ul. Leona Kruczkowskiego 8
Warsaw; Mazowieckie; Postal Code: 00-380

Contact Details: Purchase the Ucb Pharma Sp. z o.o. report to view the information.

Website: http://www.ucb.pl

Basic Information
Total Employees:
Purchase the Ucb Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Ucb Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ucb Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Ucb Pharma Sp. z o.o. report to view the information.
Incorporation Date:
July 08, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
78.05%
Purchase this report to view the information.
21.95%
Company Performance
Financial values in the chart are available after Ucb Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
15.67%
Total operating revenue
14.54%
Operating profit (EBIT)
2.57%
Net Profit (Loss) for the Period
-0.89%
Total assets
11.16%
Total equity
-9.34%
Operating Profit Margin (ROS)
-0.63%
Net Profit Margin
-0.67%
Return on Equity (ROE)
1.24%
Quick Ratio
-0.27%
Cash Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?